1h Free Analyst Time
The publisher has been monitoring the blood glucose monitoring system market and it is poised to grow by $ 5.62 billion during 2022-2026, accelerating at a CAGR of 9.06% during the forecast period. The report on the blood glucose monitoring system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the availability of reimbursement for BGM devices, the growing prevalence of diabetes, and the increasing number of product launches.
The blood glucose monitoring system market analysis includes the product segment and geographic landscape.
The analyst's blood glucose monitoring system market is segmented as below:
By Product
- Self-monitoring
- Continuous glucose monitoring devices
By Geographical Landscape:
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the rising demand for continuous blood glucose monitoring (CGM) devices as one of the prime reasons driving the blood glucose monitoring system market growth during the next few years. Also, increased adoption of bundled product marketing strategy and recent development will lead to sizable demand in the market.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The report on blood glucose monitoring system market covers the following areas:
- Blood glucose monitoring system market sizing
- Blood glucose monitoring system market forecast
- Blood glucose monitoring system market industry analysis
The analyst's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood glucose monitoring system market vendors that include Abbott Laboratories, ACON Laboratories Inc., ARKRAY Inc., B. Braun SE, Dexcom Inc., DiaMonTech AG, F. Hoffmann La Roche Ltd., GlySens Inc., i-SENS Inc., Indigo Diabetes NV, Intuity Medical Inc., Koninklijke Philips NV, LifeScan IP Holdings LLC, Medtronic Plc, Nipro Corp., OK Biotech Co. Ltd., PHC Holdings Corp., Prodigy Diabetes Care LLC, WaveForm Technologies Inc., and Ypsomed Holding AG. Also, the blood glucose monitoring system market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global blood glucose monitoring system market: Abbott Laboratories, ACON Laboratories Inc., ARKRAY Inc., B. Braun SE, Dexcom Inc., DiaMonTech AG, F. Hoffmann La Roche Ltd., GlySens Inc., i-SENS Inc., Indigo Diabetes NV, Intuity Medical Inc., Koninklijke Philips NV, LifeScan IP Holdings LLC, Medtronic Plc, Nipro Corp., OK Biotech Co. Ltd., PHC Holdings Corp., Prodigy Diabetes Care LLC, WaveForm Technologies Inc., and Ypsomed Holding AG.Commenting on the report, an analyst said: "The latest trend gaining momentum in the market is rising demand for continuous blood glucose monitoring (CGM) devices."
According to the report, one of the major drivers for this market is the availability of reimbursement for BGM devices.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- ACON Laboratories Inc.
- ARKRAY Inc.
- B. Braun SE
- Dexcom Inc.
- DiaMonTech AG
- F. Hoffmann La Roche Ltd.
- GlySens Inc.
- i-SENS Inc.
- Indigo Diabetes NV
- Intuity Medical Inc.
- Koninklijke Philips NV
- LifeScan IP Holdings LLC
- Medtronic Plc
- Nipro Corp.
- OK Biotech Co. Ltd.
- PHC Holdings Corp.
- Prodigy Diabetes Care LLC
- WaveForm Technologies Inc.
- Ypsomed Holding AG
